Breast Cancer Breakthrough News
|
|
Aug 1, 2008
H. pylori Treatment
Reduces Metachronous Stomach Cancer Risk |
|
|
By
Charles Bankhead, Staff Writer, MedPage Today
SAPPORO, Japan, Aug. 1
-- After resected early-stage gastric cancer,
prophylactic eradication of Helicobacter pylori
significantly reduces the risk of metachronous
disease, investigators here reported. <READ
MORE> |
|
|
|
|
May
16, 2008
ASCO: Missing Mutations Hold Clue to Imatinib (Gleevec)
GIST Resistance |
|
|
By
Michael Smith, North American Correspondent, MedPage Today
PHILADELPHIA, May 16
-- Some imatinib (Gleevec)-resistant patients with
gastrointestinal stromal tumors (GIST) don't respond
because they are missing the mutations in two genes
that are usually integral to the disease. <READ
MORE> |
|
|
|
|
Mar
12, 2008
Chemotherapy Offers
Little Benefit for Localized Stomach Cancer |
|
|
By
Crystal Phend, Staff Writer, MedPage Today
FLORENCE, Italy, March
12 -- Combination chemotherapy may not improve
survival for nonmetastatic gastric cancer after
surgery, results of a randomized clinical trial
suggested. <READ
MORE> |
|
|
|
|
Jan
28, 2008
ASCO GI: Sunitinib
Shows Good Real-World Imatinib-Resistant GIST
Results |
|
|
By
Ed Susman, Contributing Writer, MedPage Today
ORLANDO, Jan. 28 --
Patients with gastrointestinal stromal tumor (GIST)
who didn't make it into the formal phase III trials
of sunitinib (Sutent) for imatinib (Gleevec)-resistant
disease did well anyway, investigators reported
here. <READ
MORE> |
|
|
|
|
Jan
25, 2008
ASCO GI: Serum Imatinib
(Gleevec) Levels Predict GIST Response |
|
|
By
Peggy Peck, Executive Editor, MedPage Today
ORLANDO, Jan.25 --
Higher circulating levels of imatinib (Gleevec)
correlated with better clinical responses in
patients with gastrointestinal stromal tumors
(GIST), but proper initial doses were unpredictable,
a researcher reported here. <READ
MORE> |
|
|
|
|
Aug
14, 2007
Gastric Cancer Rate Should Drop Significantly |
|
|
By
Charles Bankhead, Staff Writer, MedPage Today
ROTTERDAM, The
Netherlands, Aug. 14 -- The incidence of gastric
cancer in developed Western nations will decrease by
24% during the next 10 years, investigators have
concluded. <READ
MORE> |
|
|
|
|
|
|
|
:: 12 Element Approach :: |
 |
|
 |
 |
Explore
and supplement your therapy with ICare's
unique 12-Element approach to Patient
Survival. |
|
 |
 |
|
:: Breakthrough News :: |
 |
|
 |
 |
Breaking
news on research for gentler, more
effective therapies and information on
lifesaving treatment options. |
|
|
|
|
|
:: ICare Bulletin Board :: |
 |
|
 |
 |
View
pertinent information regarding meetings
and events pertaining to cancer
patients. This is also a resource for
contacting other patients about
information and treatment options.
|
|
|
|
|
|
|
